Indian drug firms reeling under US anti-trust row

Sun Pharma, Dr Reddy's Laboratories have also been dragged to the court by KPH Healthcare services

Indian pharmaceutical companies and their subsidiaries in the United States are facing tremendous pressure as they tackle legalities after being accused of anti-trust activities. Among the allegations are rigging prices of drugs and colluding to delay entry of drugs in the market.
 

This challenge is over and above the pricing wars that regularly pit pharmaceutical companies against each other in courts. In a recent case, filed last week in the court of Pennsylvania, Ranbaxy has been accused of paying its rival Cephalon, to delay the entry of Provigil, a drug used to treat narcolepsy. The charge stemmed from a deal